Hemolysis: Clinical Trials

2 trials for Hemolysis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Unknown 2

Follow Hemolysis: new trials by email Literature Review of Hemolysis trials Research Report on Hemolysis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunogenicity and Safety of BBIBP-Corv Coadministered With PPV23 and IIV4 in Hemodialysis Population
coadministration, COVID-19 vaccine, IIV4+PPV23 - Hemolysis, COVID-19
Phase 4UnknownChina National Biotec Group Company Limited12002022-08-052022-08-30
Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST)
Aspirin, Clopidogrel - G6PD Deficiency, Stroke
Phase 4UnknownFirst Affiliated Hospital, Sun Yat-Sen University4402020-01-222022-03-16

Narrower conditions

COVID-19 (1)  ·  Glucosephosphate Dehydrogenase Deficiency (1)  ·  Ischemic Stroke (1)  ·  Stroke (1)

Broader conditions

Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Anemia (1)  ·  Anemia, Hemolytic (1)  ·  Anemia, Hemolytic, Congenital (1)  ·  Brain Diseases (1)  ·  Carbohydrate Metabolism, Inborn Errors (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Genetic Diseases, Inborn (1)  ·  Hematologic Diseases (1)

Interventions

Aspirin (1)  ·  COVID-19 Vaccines (1)  ·  Clopidogrel (1)

Sponsors

China National Biotec Group Company Limited (1)  ·  First Affiliated Hospital, Sun Yat-Sen University (1)

Countries

China (2)

Top investigators

Jinsheng Zeng, MD,PhD (1)  ·  Tao Huang (1)